These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8079955)

  • 1. Maintenance treatment with ranitidine.
    David J
    Am J Gastroenterol; 1994 Sep; 89(9):1597-8. PubMed ID: 8079955
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
    Massarrat S; Ihm P; Koch HK
    Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Zantac (ranitidine) in treating duodenal ulcers].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2002; (3):68-70, 121. PubMed ID: 12353395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
    Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
    Carrère MO; Auquier P; Poynard T; Sambuc R
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of ranitidine in duodenal ulcerous disease].
    Mignon M; Fontaine H
    Rev Med Suisse Romande; 1995 Oct; 115(10):789-93. PubMed ID: 7501931
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine bismuth citrate therapy.
    Harris A; Misiewicz JJ
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1035. PubMed ID: 8971307
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study.
    Manes G; Domínguez-Muñoz JE; Uomo G; Labenz J; Hackelsberger A; Malfertheiner P
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):28-33. PubMed ID: 9615260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine and recurrent hemorrhage from duodenal ulcer.
    Loffeld RJ; van der Putten AB
    N Engl J Med; 1994 Jul; 331(1):53; author reply 53-4. PubMed ID: 8202110
    [No Abstract]   [Full Text] [Related]  

  • 13. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication in duodenal ulcer disease is cost-beneficial: a Belgian model.
    Deltenre M; Ilunga KO
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():107-13. PubMed ID: 9440061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
    Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
    Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
    Maniatis AG; Brazer SR
    Am J Gastroenterol; 1994 Jun; 89(6):947-8. PubMed ID: 8198114
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.